Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice

被引:0
|
作者
Labow, M
Shuster, D
Zetterstrom, M
Nunes, P
Terry, R
Cullinan, EB
Bartfai, T
Solorzano, C
Moldawer, LL
Chizzonite, R
McIntyre, KW
机构
[1] DEPT NEUROCHEM & NEUROTOXICOL,ARRHENIUS LABS NAT SCI,STOCKHOLM,SWEDEN
[2] CHILDRENS HOSP PHILADELPHIA,ABRAMSON CTR,JOSEPH STOKES JR RES INST,PHILADELPHIA,PA 19104
[3] UNIV FLORIDA,COLL MED,DEPT SURG,GAINESVILLE,FL 32610
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 alpha and IL-1 beta are potent inflammatory cytokines that contribute to a number of normal physiologic processes and to the development of a number of inflammatory diseases, Two IL-1R, the type I and type II receptors, have been identified, This work describes the derivation and characterization of mice deficient in expression of the type I IL-1R (IL-1RI), IL-1RI-deficient mice were viable and fertile, but failed to respond to IL-1 in a variety of assays, including IL-1-induced IL-6 and E-selectin expression and IL-1-induced fever, Similar to IL-1 beta-deficient mice, IL-1RI-deficient mice had a reduced acute phase response to turpentine, In contrast, IL-1RI-deficient mice had a reduced delayed-type hypersensitivity response and were highly susceptible to infection by Listeria monocytogenes, These data demonstrate that the IL-1RI is essential for all IL-1-mediated signaling events examined, and that both IL-1 alpha and IL-1 beta are critical to the animals' response to injury and infection, These data also demonstrate that IL-1 function is not required for normal development or homeostasis.
引用
收藏
页码:2452 / 2461
页数:10
相关论文
共 50 条
  • [31] Contributions of IL-1β and IL-1α to crescentic glomerulonephritis in mice
    Timoshanko, JR
    Kitching, AR
    Iwakura, Y
    Holdsworth, SR
    Tipping, PG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04): : 910 - 918
  • [32] THE INTERACTION OF IL-1 WITH THE IL-1 RECEPTOR (TYPE-I) RECRUITS A CYTOSOLIC PROTEIN-KINASE
    HUANG, S
    SINGH, R
    KONIECZKOWSKI, M
    SEDOR, JR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 794 - 794
  • [33] IL-1 INDUCES RAPID PHOSPHORYLATION OF THE IL-1 RECEPTOR
    GALLIS, B
    PRICKETT, KS
    JACKSON, J
    SLACK, J
    SCHOOLEY, K
    SIMS, JE
    DOWER, SK
    JOURNAL OF IMMUNOLOGY, 1989, 143 (10): : 3235 - 3240
  • [34] Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
    Glaccum, MB
    Stocking, KL
    Charrier, K
    Smith, JL
    Willis, CR
    Maliszewski, C
    Livingston, DJ
    Peschon, JJ
    Morrissey, PJ
    JOURNAL OF IMMUNOLOGY, 1997, 159 (07): : 3364 - 3371
  • [35] IL-1β signaling initiates inflammatory hypernociception
    White, Fletcher A.
    Jones, Kathryn J.
    BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (07) : 1014 - 1015
  • [36] Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling
    Zhou, Jianjie
    Xiao, Yu
    Ren, Yifei
    Ge, Jiwan
    Wang, Xinquan
    ISCIENCE, 2022, 25 (07)
  • [37] Reproduction in mice lacking a functional type 1 IL-1 receptor
    Abbondanzo, SJ
    Cullinan, EB
    McIntyre, K
    Labow, MA
    Stewart, CL
    ENDOCRINOLOGY, 1996, 137 (08) : 3598 - 3601
  • [38] IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents
    Hanawa, Haruo
    Ota, Yoshimi
    Ding, Limin
    Chang, He
    Yoshida, Kaori
    Otaki, Keita
    Hao, Kazuhisa
    Kasahara, Sou
    Kodama, Makoto
    Nakazawa, Mikio
    Aizawa, Yoshifusa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (03) : 455 - 464
  • [39] Astrocytic ceruloplasmin expression, which is induced by IL-1β and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor
    Kuhlow, CJ
    Krady, JK
    Basu, A
    Levison, SW
    GLIA, 2003, 44 (01) : 76 - 84
  • [40] IL-1 Receptor Accessory Protein-Ig/IL-1 Receptor Type II-Ig Heterodimer Inhibits IL-1 Response More Strongly than Other IL-1 Blocking Biopharmaceutical Agents
    Haruo Hanawa
    Yoshimi Ota
    Limin Ding
    He Chang
    Kaori Yoshida
    Keita Otaki
    Kazuhisa Hao
    Sou Kasahara
    Makoto Kodama
    Mikio Nakazawa
    Yoshifusa Aizawa
    Journal of Clinical Immunology, 2011, 31 : 455 - 464